To determine comparative rates of development and progression of peripheral occlusive arterial disease, 110 healthy nondiabetic control subjects, 112 patients with peripheral occlusive arterial disease (POAD), 240 patients with diabetes mellitus (DM), and 100 patientswith diabetes mellitus and peripheral occlusive arterialdisease (DM + POAD) were studied over 4 yr with noninvasive techniques. The presence of peripheral occlusive arterial disease was determined by postexercise ankle-brachial index (ABI) values; progression of peripheral occlusive arterial disease was determined by the rate of change in postexercise ABI. Patients who underwent peripheral arterial reconstructive surgery or amputation were also classified as having progression of their peripheral occlusive arterial disease. On this basis, follow-up revealed that peripheral occlusive arterial disease developed and therefore progressed in 1 (1%) of the control group and 22 (9%) of the DM. Peripheral occlusive arterial disease progressed in 31 (28%) of the POAD and 26 (26%) of the DM + POAD. The presence of peripheral occlusive arterial disease predisposes to progression of disease, and peripheral occlusive arterial disease is more likely to develop in diabetic patients who do not have peripheral occlusive arterial disease than in nondiabetic control subjects. However, the presence of diabetes mellitus in patients with peripheral occlusive arterial disease does not seem to increase the risk of progression.
Skip Nav Destination
Article navigation
Original Articles|
February 01 1990
Course of Peripheral Occlusive Arterial Disease in Diabetes: Vascular Laboratory Assessment
Philip J Osmundson, MD;
Philip J Osmundson, MD
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
W Michael O'Fallon, PhD;
W Michael O'Fallon, PhD
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
Bruce R Zimmerman, MD;
Bruce R Zimmerman, MD
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
Francis J Kazmier, MD;
Francis J Kazmier, MD
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
Alice L Langworthy, AB;
Alice L Langworthy, AB
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
P J Palumbo, MD
P J Palumbo, MD
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Division of Endocrinology
Metabolism
Internal Medicine, Mayo Clinic and Mayo Foundation
Rochester, Minnesota
Search for other works by this author on:
Address correspondence and reprint requests to Philip J. Osmundson, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Diabetes Care 1990;13(2):143–152
Article history
Received:
July 11 1988
Accepted:
August 02 1989
PubMed:
2351012
Citation
Philip J Osmundson, W Michael O'Fallon, Bruce R Zimmerman, Francis J Kazmier, Alice L Langworthy, P J Palumbo; Course of Peripheral Occlusive Arterial Disease in Diabetes: Vascular Laboratory Assessment. Diabetes Care 1 February 1990; 13 (2): 143–152. https://doi.org/10.2337/diacare.13.2.143
Download citation file: